SCHEMBL30833729

SCHEMBL30833729

CS(=O)(=O)N1CCCc2cccc(N)c21

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.45
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
ALOX12 P18054 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
ATM Q13315 1/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NLRP3 Q96P20 3/20 0.38
EIF2AK2 P19525 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29190645 1.00 CES1 (0.45) CES1RAB9AALDH1A1KDM4EHPGD
SCHEMBL24327585 0.90 CYP11B1 (0.38) CES1RAB9AHPGDKMT2AMEN1
SCHEMBL14591325 0.83 ALOX12 (0.56) CES1RAB9AALDH1A1KDM4EHPGD
SCHEMBL19603146 0.80 RAB9A (0.41) CES1RAB9AALDH1A1KDM4EHPGD
SCHEMBL5915385 0.77 KMT2A (0.52) RAB9AALDH1A1KDM4EHPGDHTT
SCHEMBL30833753 0.77 KMT2A (0.54) CES1RAB9AALDH1A1KDM4EHPGD
SCHEMBL29190601 0.77 KMT2A (0.54) CES1RAB9AALDH1A1KDM4EHPGD
SCHEMBL19608834 0.77 NLRP3 (0.41) CES1RAB9AALDH1A1KDM4EHPGD
SCHEMBL14591403 0.76 HTR2C (0.50) RAB9AALDH1A1KDM4EHPGDHTT
SCHEMBL19601648 0.76 RAB9A (0.38) CES1RAB9AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113896744-B Selective EGFR inhibitor 成都先导药物开发股份有限公司 2024-04-16 CN disclosed
CN-117794914-A Pyrimidine-2, 4-diamine derivatives, process for preparing the same, and pharmaceutical composition for preventing or treating cancer comprising the same as active ingredient 韩国化学研究院 2024-03-29 CN disclosed